Esco Lifesciences

Singapore, Singapore Founded: 1978 • Age: 48 yrs
Manufacturer of biopharma equipment IVF medical devices, and service provider for life science tools
Request Access

About Esco Lifesciences

Esco Lifesciences is a company based in Singapore (Singapore) founded in 1978.. Esco Lifesciences has raised $400 million across 2 funding rounds from investors including Vivo Capital, Novo Holdings and China Investment Corporation. The company has 1 employees as of April 08, 2024. Esco Lifesciences has completed 2 acquisitions, including AT Medical and Evidence Solutions. Esco Lifesciences operates in a competitive market with competitors including Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Agilent, among others.

  • Headquarter Singapore, Singapore
  • Employees 1 as on 08 Apr, 2024
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Elg Lifesciences India Private Limited
  • Date of Incorporation 10 Dec, 2020
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $0 (USD)
    0
    as on Mar 31, 2022
  • Net Profit
    $-14.24 K (USD)
    -2253.78
    as on Mar 31, 2022
  • EBITDA
    $-13.21 K (USD)
    -2083.82
    as on Mar 31, 2022
  • Total Equity Funding
    $400 M (USD)

    in 2 rounds

  • Latest Funding Round
    $200 M (USD), Series A

    May 27, 2021

  • Investors
  • Employee Count
    1

    as on Apr 08, 2024

  • Investments & Acquisitions
    AT Medical

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Esco Lifesciences
Headcount 1-10
Employee Profiles 18
Board Members and Advisors 3
Employee Profiles
People
Joshua Fonseca
Technical Sales Representative
People
Ilenia Nardolillo
Regional Sales Manager
People
Low Yae-Foong
Co-Founder & COO
People
Alex Atmadi
Technical Sales Manager, North America

Unlock access to complete

Board Members and Advisors
people
Lim Lay Yew
Co-Founder & Executive Director
people
Amit Kakar
Director
people
Ang Kong Hua
Senior Advisor

Unlock access to complete

Funding Insights of Esco Lifesciences

Esco Lifesciences has successfully raised a total of $400M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $200 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $200.0M
  • First Round

    (26 May 2021)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Series A - Esco Lifesciences Valuation

investors

May, 2021 Amount Series A - Esco Lifesciences Valuation Vivo Capital , Novo Holdings
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Esco Lifesciences

Esco Lifesciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Vivo Capital, Novo Holdings and China Investment Corporation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital and private equity firm
Founded Year Domain Location
Private equity and venture capital fund focused on the healthcare sector
Founded Year Domain Location
Government-backed investments are directed toward healthcare, fintech, and various sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Esco Lifesciences

Esco Lifesciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AT Medical and Evidence Solutions. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Manufacturer of Class IIa sensors for the European markets
2011
Legal, personal injury, trucking, and aviation services are provided.
1982
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Esco Lifesciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Esco Lifesciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Esco Lifesciences

Esco Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Agilent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of molecular diagnostic testing solutions
domain founded_year HQ Location
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
domain founded_year HQ Location
Diversified research instrument systems are manufactured and supplied.
domain founded_year HQ Location
Medical devices for neurological therapies are developed.
domain founded_year HQ Location
Diversified instruments are developed for scientific and laboratory management.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Esco Lifesciences

Frequently Asked Questions about Esco Lifesciences

When was Esco Lifesciences founded?

Esco Lifesciences was founded in 1978 and raised its 1st funding round 43 years after it was founded.

Where is Esco Lifesciences located?

Esco Lifesciences is headquartered in Singapore, Singapore.

Is Esco Lifesciences a funded company?

Esco Lifesciences is a funded company, having raised a total of $400M across 2 funding rounds to date. The company's 1st funding round was a Series A of $200M, raised on May 26, 2021.

How many employees does Esco Lifesciences have?

As of Apr 08, 2024, the latest employee count at Esco Lifesciences is 1.

What does Esco Lifesciences do?

Esco Lifesciences was founded in 1978 in Singapore. Biopharma equipment and IVF medical devices are produced for the life sciences sector. Services such as installation and maintenance are offered to related industries. The portfolio encompasses cell culturing reagents, monitoring systems, incubators, hoods, and additional tools. Operations focus on supporting biopharma and reproductive health applications globally from its Singapore base.

Who are the top competitors of Esco Lifesciences?

Esco Lifesciences's top competitors include Cepheid, Blackrock Neurotech and Agilent.

How many acquisitions has Esco Lifesciences made?

Esco Lifesciences has made 2 acquisitions, including AT Medical, and Evidence Solutions.

Who are Esco Lifesciences's investors?

Esco Lifesciences has 4 investors. Key investors include Vivo Capital, Novo Holdings, China Investment Corporation, and EDBI.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available